Screener
Beta Bionics BBNX Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Cash and cash equivalents | $44,318 | $31,576 |
| Restricted cash, current | 100 | 100 |
| Short-term investments | 136,171 | 187,549 |
| Accounts receivable, net | 18,053 | 17,118 |
| Inventories | 23,918 | 21,722 |
| Prepaid expenses and other current assets | 8,474 | 9,840 |
| Total current assets | 231,034 | 267,905 |
| Property and equipment, net | 10,748 | 8,600 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's accounts receivable?
- Beta Bionics (BBNX) reported accounts receivable of $18.05M in Q2 2026.
- How has Beta Bionics's accounts receivable changed year-over-year?
- Beta Bionics's accounts receivable increased by 58.4% year-over-year, from $11.4M to $18.05M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.
Ask your AI about Beta Bionics's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude